Clinical Trial Update: Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating efficacy and safety of HLX10 in chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HLX10

Snippet

Sponsor: Henlix, Inc | Conditions: Hepatitis B, Chronic | Phase 2 | Status: UNKNOWN